Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EPRX is expected to report earnings to fall 17.58% to -15 cents per share on March 31
Q4'25
Est.
$-0.16
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 114.67K shares outstanding, the current market capitalization sits at 337.84M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EPRX showed earnings on November 04, 2025. You can read more about the earnings report here.